Stocks
Allogene Therapeutics (ALLO) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -202.0 | -258.2 | -255.8 | -335.4 | -327.7 | -279.6 | |||
| Changes by years, y/y, % | +5% | +28% | -1% | +31% | -2% | +11.2% | |||
Allogene Therapeutics. Operating Income, bln rub
Allogene Therapeutics. Operating Income, changes, %
Allogene Therapeutics. Operating Income, sum by quarters, bln rub
Allogene Therapeutics (ALLO) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | -63.0 | -71.9 | -69.5 | -66.4 | -71.8 | -279.6 | ||
| Changes by years, y/y, % | -24% | -25% | -30% | -17% | +14% | |||
| Changes by quarters, q/q, % | -22% | +14% | -3% | -4% | +8% | |||
